Insider Stock Trading History of Logan Carolyn J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Logan Carolyn J since year 2005. The trader's CIK number is 1212670. At the time of this reporting, Logan Carolyn J is the President & CEO of Salix Pharmaceuticals Ltd . (stock ticker symbol SLXP). See this page for all insider trading activities at Salix Pharmaceuticals Ltd .


Stock purchases, sales, and option exercises reported by insider Logan Carolyn J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-12-22 SLXP Salix Pharmaceuticals Ltd Option Ex 44,000 17.63 775,720
2014-06-26 SLXP Salix Pharmaceuticals Ltd Option Ex 99,375 18.87 1,875,206
2014-06-26 SLXP Salix Pharmaceuticals Ltd Sale 53,057 123.13 6,532,749
2012-12-20 SLXP Salix Pharmaceuticals Ltd Option Ex 33,750 7.60 256,500
2012-12-20 SLXP Salix Pharmaceuticals Ltd Sale 25,000 42.27 1,056,675
2012-06-28 SLXP Salix Pharmaceuticals Ltd Option Ex 228,467 4.07 929,860
2012-06-28 SLXP Salix Pharmaceuticals Ltd Sale 119,300 52.07 6,211,831
2012-06-14 SLXP Salix Pharmaceuticals Ltd Option Ex 36,534 4.07 148,693
2012-04-13 SLXP Salix Pharmaceuticals Ltd Option Ex 20,000 4.07 81,400
2010-09-21 SLXP Salix Pharmaceuticals Ltd Sale 14,000 42.35 592,858
2010-05-10 SLXP Salix Pharmaceuticals Ltd Option Ex 40,000 1.13 45,199
2010-02-19 SLXP Salix Pharmaceuticals Ltd Option Ex 35,000 1.13 39,549
2009-12-10 SLXP Salix Pharmaceuticals Ltd Option Ex 35,000 1.13 39,549
2009-09-14 SLXP Salix Pharmaceuticals Ltd Option Ex 10,000 1.13 11,299
2009-09-14 SLXP Salix Pharmaceuticals Ltd Sale 10,000 20.67 206,740
2007-11-16 SLXP Salix Pharmaceuticals Ltd Buy 7,000 10.48 73,360
2007-07-23 SLXP Salix Pharmaceuticals Ltd Option Ex 30,000 .00 0
2007-07-03 SLXP Salix Pharmaceuticals Ltd Sale 5,710 12.31 70,290
2006-05-09 SLXP Salix Pharmaceuticals Ltd Buy 7,500 13.23 99,232
2006-03-09 SLXP Salix Pharmaceuticals Ltd Option Ex 30,000 1.13 33,900

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Logan Carolyn J (President & CEO of Salix Pharmaceuticals Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.